Insider filing · AXSM
Axsome Therapeutics, Inc.
AXSM · Healthcare · 34 filings in 24 months
ticker →
Roger Jeffs sold $7.3M of Axsome Therapeutics (AXSM)
Executed Aug 27 2025, disclosed Aug 29 2025, 2 days later.
Value, as filed
$7.3M
60,000 sh across 3 lots
Executed
Aug 27 2025
the trade date, as filed
Disclosed
Aug 29 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RJ
Roger Jeffs
Director
profile →
Roger Jeffs (Director) filed 13 Form 4 reports in the trailing twelve months (0 purchases, 13 sales), most often in Liquidia Corporation (LQDA). The largest single filing was $4.6M of LQDA (75,000 sh across 3 lots, as filed), executed May 21.
The name
AXSMHealthcare · Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Roger Jeffs in AXSM
AXSMSALE
Axsome Therapeutics, Inc.
$1.7M13,464 sh × $123.68
Exec Sep 2 2025
Filed Sep 2 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $4.4M
36,694 sh across 2 lots
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET